Correlation Between CryoCell International and National HealthCare

Can any of the company-specific risk be diversified away by investing in both CryoCell International and National HealthCare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CryoCell International and National HealthCare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CryoCell International and National HealthCare, you can compare the effects of market volatilities on CryoCell International and National HealthCare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CryoCell International with a short position of National HealthCare. Check out your portfolio center. Please also check ongoing floating volatility patterns of CryoCell International and National HealthCare.

Diversification Opportunities for CryoCell International and National HealthCare

0.36

Correlation Coefficient

CryoCell International  National HealthCare

Weak diversification

The 3 months correlation between CryoCell and National is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding CryoCell International and National HealthCare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National HealthCare and CryoCell International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CryoCell International are associated (or correlated) with National HealthCare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National HealthCare has no effect on the direction of CryoCell International i.e., CryoCell International and National HealthCare go up and down completely randomly.

Pair Corralation between CryoCell International and National HealthCare

Given the investment horizon of 90 days CryoCell International is expected to generate 2.4 times more return on investment than National HealthCare. However, CryoCell International is 2.4 times more volatile than National HealthCare. It trades about 0.12 of its potential returns per unit of risk. National HealthCare is currently generating about -0.02 per unit of risk. If you would invest  645.00  in CryoCell International on September 3, 2024 and sell it today you would earn a total of  222.00  from holding CryoCell International or generate 34.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CryoCell International  vs.  National HealthCare

CryoCell International

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CryoCell International are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady technical and fundamental indicators, CryoCell International disclosed solid returns over the last few months and may actually be approaching a breakup point.

National HealthCare

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days National HealthCare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, National HealthCare is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with CryoCell International and National HealthCare

The main advantage of trading using opposite CryoCell International and National HealthCare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CryoCell International position performs unexpectedly, National HealthCare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National HealthCare will offset losses from the drop in National HealthCare's long position.

The idea behind CryoCell International and National HealthCare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.